These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26124658)

  • 1. Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency.
    Kim SW; Khang D
    Int J Nanomedicine; 2015; 10():3989-4008. PubMed ID: 26124658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.
    Sadhukha T; O'Brien TD; Prabha S
    J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.
    Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA
    Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
    Chakraborty S; Dhakshinamurthy GS; Misra SK
    J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
    Sun X; Zhang G; Wu Z
    Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization.
    Li J; Ke W; Li H; Zha Z; Han Y; Ge Z
    Adv Healthc Mater; 2015 Oct; 4(15):2206-19. PubMed ID: 26346421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Size-Tunable Hollow Polypyrrole Nanostructures and Their Assembly into Folate-Targeting and pH-Responsive Anticancer Drug-Delivery Agents.
    Chen J; Li X; Sun Y; Hu Y; Peng Y; Li Y; Yin G; Liu H; Xu J; Zhong S
    Chemistry; 2017 Dec; 23(68):17279-17289. PubMed ID: 28913948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells.
    Tung WL; Hu SH; Liu DM
    Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on applications of nanostructured drug delivery systems in cancer therapy: a review.
    Aberoumandi SM; Mohammadhosseini M; Abasi E; Saghati S; Nikzamir N; Akbarzadeh A; Panahi Y; Davaran S
    Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-11. PubMed ID: 27632797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
    Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
    Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Aptamer Based Nanodrugs: Molecular Engineering for Efficiency.
    Cansiz S; Zhang L; Wu C; Wu Y; Teng IT; Hou W; Wang Y; Wan S; Cai R; Jin C; Liu Q; Tan W
    Chem Asian J; 2015 Oct; 10(10):2084-94. PubMed ID: 26177853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled mirror DNA nanostructures for tumor-specific delivery of anticancer drugs.
    Kim KR; Kim HY; Lee YD; Ha JS; Kang JH; Jeong H; Bang D; Ko YT; Kim S; Lee H; Ahn DR
    J Control Release; 2016 Dec; 243():121-131. PubMed ID: 27746274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
    Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
    Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.